We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+0.26%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$30.7B
AUM Growth
+$988M
(+3.3%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.28%
Top 10 Holdings %
Top 10 Hldgs %
54.65%
Holding
2,179
New
164
Increased
802
Reduced
752
Closed
188
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$124M |
| 2 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$122M |
| 3 |
Alerian MLP ETF
AMLP
|
+$112M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$84.3M |
| 5 |
Schwab International Equity ETF
SCHF
|
+$75.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$92.7M |
| 2 |
TSS
Total System Services, Inc.
TSS
|
+$49.4M |
| 3 |
Vanguard Mid-Cap ETF
VO
|
+$25.4M |
| 4 |
Schwab US REIT ETF
SCHH
|
+$23.4M |
| 5 |
Apple
AAPL
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.77% |
| 2 | Technology | 4.11% |
| 3 | Healthcare | 1.86% |
| 4 | Consumer Discretionary | 1.76% |
| 5 | Industrials | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Halliburton
HAL
$27.9B
| $2.11M | 0.01% |
111,988
+18,061
| +19% | +$374K |
|
|
PPL
477
PPL Corp
PPL
$27.3B
| $2.09M | 0.01% |
66,342
-4,866
| -7% | -$147K |
|
478
Zimmer Biomet
ZBH
$17.7B
| $2.08M | 0.01% |
15,618
-1,384
| -8% | -$179K |
|
479
TSMC
TSM
$2.09T
| $2.08M | 0.01% |
44,717
-4,259
| -9% | -$182K |
|
480
Palo Alto Networks
PANW
$264B
| $2.07M | 0.01% |
60,966
+996
| +2% | +$35.3K |
|
|
MPT
481
Medical Properties Trust
MPT
$2.89B
| $2.06M | 0.01% |
105,429
+2,340
| +2% | +$43K |
|
482
Williams Companies
WMB
$90.5B
| $2.05M | 0.01% |
85,221
+556
| +0.7% | +$14K |
|
483
AGNC Investment
AGNC
$12.3B
| $2.05M | 0.01% |
127,287
-2,640
| -2% | -$43.3K |
|
484
Rollins
ROL
$18.6B
| $2.05M | 0.01% |
90,173
-453
| -0.5% | -$10.4K |
|
|
EVV
485
Eaton Vance Limited Duration Income Fund
EVV
$1.06B
| $2.03M | 0.01% |
162,599
+19,874
| +14% | +$250K |
|
486
Johnson Controls International
JCI
$87.5B
| $2.03M | 0.01% |
46,259
-1,882
| -4% | -$79.7K |
|
487
Schwab Short-Term US Treasury ETF
SCHO
$12.7B
| $2.02M | 0.01% |
80,016
-14,238
| -15% | -$360K |
|
488
SAP
SAP
$187B
| $2.02M | 0.01% |
17,134
-73
| -0.4% | -$9.04K |
|
489
Schwab US Large-Cap Growth ETF
SCHG
$58.5B
| $2.01M | 0.01% |
190,984
+13,144
| +7% | +$139K |
|
490
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$18.7B
| $2M | 0.01% |
176,730
+122,400
| +225% | +$1.33M |
|
|
RDHL
491
Redhill Biopharma
RDHL
$3.85M
| $2M | 0.01% |
284
+1
| +0.4% | +$7.28K |
|
492
Keysight
KEYS
$54.5B
| $2M | 0.01% |
20,534
-1,294
| -6% | -$120K |
|
493
Monster Beverage
MNST
$91.4B
| $1.99M | 0.01% |
68,484
-486
| -0.7% | -$14.7K |
|
494
Moody's
MCO
$82.4B
| $1.98M | 0.01% |
9,673
-56
| -0.6% | -$11.7K |
|
495
AB InBev
BUD
$158B
| $1.98M | 0.01% |
20,799
-147
| -0.7% | -$13.9K |
|
496
Darden Restaurants
DRI
$22.5B
| $1.98M | 0.01% |
16,739
+1,092
| +7% | +$133K |
|
497
Knowles
KN
$3.22B
| $1.97M | 0.01% |
96,973
+100
| +0.1% | +$1.96K |
|
498
EPR Properties
EPR
$4.86B
| $1.97M | 0.01% |
25,618
-397
| -2% | -$30.2K |
|
499
Karyopharm Therapeutics
KPTI
$168M
| $1.96M | 0.01% |
+13,597
| New | +$1.84M |
|
|
CHK
500
DELISTED
Chesapeake Energy Corporation
CHK
| $1.95M | 0.01% |
6,922
-4,947
| -42% | -$1.61M |
|
Similar funds
Creative Planning's Q3 2019 Portfolio in Review
As of Q3 2019, Creative Planning held 2,179 positions worth $30.7B, up 3.3% from $29.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Creative Planning deployed $1.01B of net new capital in Q3 2019, opening 164 new positions and adding to 802 existing holdings. Its largest new stake was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
By sector, the portfolio is most concentrated in Financials at 4.8% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $92.7M trimmed.
- Creative Planning's largest Q3 2019 buy was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
- Creative Planning added most to iShares Core US Aggregate Bond ETF in Q3 2019, an estimated $124M increase.
- Creative Planning's biggest Q3 2019 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $92.7M.
- Creative Planning fully exited Total System Services, Inc. in Q3 2019, selling an estimated $49.4M.
- Creative Planning's ten largest holdings make up 55% of its $30.7B portfolio in Q3 2019.
- Creative Planning opened 164 new positions and closed 188 in Q3 2019.
- Creative Planning's portfolio value rose 3.3% quarter-over-quarter to $30.7B.
Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.